share_log

4: Statement of changes in beneficial ownership of securities-Director McNealey Jennifer Isacoff

4: Statement of changes in beneficial ownership of securities-Director McNealey Jennifer Isacoff

4：持股變動聲明-董事 McNealey Jennifer Isacoff
美股SEC公告 ·  05/15 16:55

Moomoo AI 已提取核心訊息

Jennifer Isacoff McNealey, associated with Conduit Pharmaceuticals, has engaged in a transaction involving the company's stock on May 13, 2024. The specific details of the transaction, including the number of shares, the nature of the shares, the transaction price, and the total value of the shares, have not been disclosed. The action type and status, as well as the number of shares held by McNealey after the transaction, are also not provided in the announcement.
Jennifer Isacoff McNealey, associated with Conduit Pharmaceuticals, has engaged in a transaction involving the company's stock on May 13, 2024. The specific details of the transaction, including the number of shares, the nature of the shares, the transaction price, and the total value of the shares, have not been disclosed. The action type and status, as well as the number of shares held by McNealey after the transaction, are also not provided in the announcement.
與Conduit Pharmicals有聯繫的詹妮弗·艾薩科夫·麥克尼利於2024年5月13日參與了一項涉及該公司股票的交易。該交易的具體細節，包括股票數量、股票的性質、交易價格和股票的總價值，尚未披露。公告中也沒有提供行動類型和狀態以及McNealey在交易後持有的股票數量。
與Conduit Pharmicals有聯繫的詹妮弗·艾薩科夫·麥克尼利於2024年5月13日參與了一項涉及該公司股票的交易。該交易的具體細節，包括股票數量、股票的性質、交易價格和股票的總價值，尚未披露。公告中也沒有提供行動類型和狀態以及McNealey在交易後持有的股票數量。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間